References
- Rook GA, Raison CL, Lowry CA. Can we vaccinate against depression? Drug Discov Today. 2012;17:451–458.
- Canli T. Reconceptualizing major depressive disorder as an infectious disease. Biol Mood Anxiety Disord. 2014;4:10.
- Garay RP, Zarate CA Jr., Charpeaud T, et al. Investigational drugs in recent clinical trials for treatment-resistant depression. Expert Rev Neurother. 2017;1–17.doi: 10.1080/14737175.2017.1283217.
- Sudo N, Chida Y, Aiba Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004;558:263–275.
- Nishino R, Mikami K, Takahashi H, et al. Commensal microbiota modulate murine behaviors in a strictly contamination-free environment confirmed by culture-based methods. Neurogastroenterol Motil. 2013;25:521–528.
- Lombard M, Pastoret PP, Moulin AM. A brief history of vaccines and vaccination. Rev Sci Tech. 2007;26:29–48.
- Lyte M, Varcoe JJ, Bailey MT. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol Behav. 1998;65:63–68.
- Goehler LE, Gaykema RP, Opitz N, et al. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun. 2005;19:334–344.
- Lyte M, Li W, Opitz N, et al. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav. 2006;89:350–357.
- Kim YK, Na KS, Myint AM, et al. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2016;64:277–284.
- Maes M, Kubera M, Leunis JC, et al. Increased iga and igm responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J Affect Disord. 2012;141:55–62.
- Van Dooren FE, Schram MT, Schalkwijk CG, et al. Associations of low grade inflammation and endothelial dysfunction with depression - the Maastricht study. Brain Behav Immun. 2016;56:390–396.
- Jiang H, Ling Z, Zhang Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186–194.
- George VT, George AK, John S, et al. Periodontal vaccine: A therapeutic modality on the horizon? Saudi J Dental Res. 2015;6:73–78.
- Choi JI, Seymour GJ. Vaccines against periodontitis: A forward-looking review. J Periodontal Implant Sci. 2010;40:153–163.
- Oxenkrug G. Serotonin-kynurenine hypothesis of depression: historical overview and recent developments. Curr Drug Targets. 2013;14:514–521.
- Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011;141(599–609):e1–e3.
- Nguyen TL, Vieira-Silva S, Liston A, et al. How informative is the mouse for human gut microbiota research? Dis Model Mech. 2015;8:1–16.
- Van Voorhees BW, Gladstone T, Cordel S, et al. Development of a technology-based behavioral vaccine to prevent adolescent depression: A health system integration model. Internet Interventions. 2015;2:303–313.
- Beck T. A vaccine for depression? Ketamine’s remarkable effect bolsters a new theory of mental illness. Nautilus. Biology. Neuroscience. 2015 cited 2016 Oct 12. Available from http://nautil.us/issue/31/stress/a-vaccine-for-depression
- Reber SO, Siebler PH, Donner NC, et al. Immunization with a heat-killed preparation of the environmental bacterium Mycobacterium vaccae promotes stress resilience in mice. Proc Natl Acad Sci U S A. 2016;113:E3130–9.
- Mole B. Vaccine against stress and anxiety made using dead gut microbes of yore. Ars Technica. 2016 cited 2016 Oct 6. Available from http://arstechnica.com/science/2016/05/old-friend-gut-microbes-may-immunize-against-stress-and-anxiety/
- Reardon S. Vaccine hope for post-traumatic stress. Nature. 2015 cited 2016 Oct 6. Available from http://www.nature.com/news/vaccine-hope-for-post-traumatic-stress-1.17746
- Peters E, Mehta RL, Murray PT, et al. Study protocol for a multicentre randomised controlled trial: safety, tolerability, efficacy and quality of life of a human recombinant alkaline phosphatase in patients with sepsis-associated acute kidney injury (stop-aki). BMJ Open. 2016;6:e012371.